Clinical Trial Update: Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing esomeprazole and pantoprazole for preventing peptic ulcer rebleeding has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Pantoprazole (pantoprazole)

Snippet

Sponsor: Lotung Poh-Ai Hospital | Conditions: Peptic Ulcer | Phase 4 | Status: WITHDRAWN